Serina Therapeutics (SER) Leases (2019 - 2025)
Serina Therapeutics (SER) has disclosed Leases for 5 consecutive years, with $362000.0 as the latest value for Q2 2025.
- Quarterly Leases rose 122.09% to $362000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $362000.0 through Jun 2025, up 122.09% year-over-year, with the annual reading at $461000.0 for FY2024, 182.82% up from the prior year.
- Leases hit $362000.0 in Q2 2025 for Serina Therapeutics, up from $81000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $509000.0 in Q3 2024 to a low of $81000.0 in Q1 2025.
- Historically, Leases has averaged $271714.3 across 3 years, with a median of $163000.0 in 2023.
- Biggest five-year swings in Leases: skyrocketed 182.82% in 2024 and later tumbled 50.31% in 2025.
- Year by year, Leases stood at $163000.0 in 2023, then surged by 182.82% to $461000.0 in 2024, then fell by 21.48% to $362000.0 in 2025.
- Business Quant data shows Leases for SER at $362000.0 in Q2 2025, $81000.0 in Q1 2025, and $461000.0 in Q4 2024.